Catalyst Wire Dossier Catalyst Wire Dossier

Tiotropium (Respimat) 5 mcg

tiotropium · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tiotropium (Respimat) 5 mcg, covering 2013-11-01 to 2013-11-01. Get the full timeline:

Most recent: Clinical Trial Update: 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [Phase 3]

See pricing